Table 3.
Association Between Hepatic Steatosis and Other Parameters.
| Parameters | Steatosis |
P value | |
|---|---|---|---|
| Present (n = 58) | Absent (n = 13) | ||
| Age (Years) | 48.76 ± 12.06 | 48.81 ± 12.81 | 0.9871 |
| Gender | 0.4373 | ||
| Male | 27 (60.0%) | 18 (69.2%) | |
| Female | 18 (40.0%) | 8 (30.8%) | |
| BMI (kg/m2)∗∗∗ | 31.34 ± 6.45 | 27.16 ± 5.21 | 0.0094 |
| Metabolic Syndrome ∗∗∗ | 32 (55.2%) | 2 (15.4%) | 0.0091 |
| Diabetes | 18 (31.0%) | 1 (7.7%) | 0.1622 |
| Severity of OSA | 0.0793 | ||
| Mild | 5 (11.1%) | 7 (26.9%) | |
| Moderate | 11 (24.4%) | 9 (34.6%) | |
| Severe | 29 (64.4%) | 10 (38.5%) | |
| AHI∗∗∗ | 47.25 ± 27.01 | 28.75 ± 18.27 | 0.0054 |
| ODI∗∗∗ | 51.13 ± 29.09 | 30.48 ± 19.20 | 0.0054 |
| T90 (%)∗∗∗ | 14.95 ± 22.48 | 3.24 ± 5.40 | 0.0034 |
| Sleep Efficiency (%) | 75.76 ± 13.63 | 74.84 ± 13.15 | 0.7811 |
| AST (U/L)∗∗∗ | 50.73 ± 38.56 | 31.85 ± 13.85 | 0.0074 |
| ALT (U/L) | 56.84 ± 38.71 | 38.92 ± 15.91 | 0.1094 |
| ALP (U/L)∗∗∗ | 122.47 ± 45.52 | 100.54 ± 43.61 | 0.0384 |
| GGT (U/L) | 35.87 ± 18.84 | 30.46 ± 17.74 | 0.3334 |
| Fasting plasma insulin (mU/L)∗∗∗ | 20.99 ± 12.34 | 10.27 ± 6.81 | <0.0014 |
| HOMA-IR∗∗∗ | 133.54 ± 84.76 | 61.71 ± 41.09 | 0.0014 |
| Fasting blood glucose (mmol/dL) | 7.97 ± 12.40 | 5.98 ± 0.80 | 0.7244 |
| Total Cholesterol (mg/dL)∗∗∗ | 213.31 ± 55.22 | 176.42 ± 34.19 | 0.0054 |
| Total HDL (mg/dL) | 47.72 ± 9.41 | 47.81 ± 7.99 | 0.9691 |
| Total LDL (mg/dL)∗∗∗ | 138.73 ± 37.92 | 118.23 ± 29.05 | 0.0214 |
| Serum Triglyceride (mg/dL) | 163.98 ± 69.56 | 161.73 ± 43.21 | 0.8954 |
∗∗∗Significant at P < 0.05.
AHI, Apnea-hypopnea Index; ALP, Alkaline phosphatase; ALT, Alanine aminotransferase; AST, Aspartate aminotransferase; BMI, Body mass index; GGT, Gamma-glutaryl transferase; HDL, High densoty lipoprotein; HOMA-IR, Homeostasis model assessment-estimated insulin resistance; LDL, Low density lipoprotein; ODI, Oxygen desaturation index; OSA, Obstructive sleep apnea.
t-test.
Fisher's Exact Test.
Chi-Squared Test.
Wilcoxon-Mann-Whitney U Test.